BMEA
BMEA
NASDAQ · Biotechnology

Biomea Fusion Inc

$1.47
+0.08 (+5.76%)
As of Jun 30, 10:35 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 11 85%
Hold 1 8%
Sell 1 8%
Price Target
Analyst Price Target +91.8% upside
Low Target $1.78
Average Target $2.82
High Target $3.37
Current Price $1.47
Current
$1.47
Target
$2.82
$1.78 $2.82 avg $3.37
Scenario Analysis
Bear Case
$1.78
21.1%
Low target
Base Case
$2.82
+91.8%
Avg target
Bull Case
$3.37
+129.3%
High target
Risk/Reward
6.1x
Highly favorable
Price in Context
52-Week High
$2.99
-50.8% from high
52-Week Low
$0.87
+68.6% from low
Target vs 52W High
$2.82
-5.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%